Company Filing History:
Years Active: 2001
Introduction
John Andrew Printen is an accomplished inventor based in Ann Arbor, Michigan, known for his contributions to the field of biotechnology. With a focus on protein targeting, Printen has made significant strides that have implications for various biological processes.
Latest Patents
Printen holds a patent for "Protein Targeting to Glycogen." This invention encompasses human and murine genomic and complementary DNA, as well as the proteins encoded by this DNA. The patent also details a method to increase the amount of glycogen in a cell, showcasing Printen’s innovative approach to enhancing cellular functions.
Career Highlights
Throughout his career, John Andrew Printen has been associated with the Warner-Lambert Company, where he has applied his expertise in molecular biology to advance research and development in the field. His work has been pivotal in bridging new scientific discoveries with practical applications.
Collaborations
In his professional journey, Printen has collaborated with notable colleagues such as Matthew Jemail Brady and Alan Robert Saltiel. These collaborations have fostered an environment of innovation and contributed to multiple advancements in the field of biotechnology.
Conclusion
John Andrew Printen exemplifies the spirit of innovation in the realm of biotech with his patent on protein targeting to glycogen. His work at Warner-Lambert Company, along with his collaborative efforts, highlights the importance of interdisciplinary teamwork in driving significant advancements in science.